Financial Freedom LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$745K Hold
621
0.34% 57
2026
Q1
$571K Buy
621
+1
+0.2% +$1.01K 0.28% 57
2025
Q4
$667K Hold
620
0.33% 57
2025
Q3
$473K Sell
620
-41
-6% -$30.5K 0.24% 68
2025
Q2
$515K Buy
661
+59
+10% +$45.8K 0.28% 60
2025
Q1
$497K Hold
602
0.29% 61
2024
Q4
$464K Buy
602
+1
+0.2% +$828 0.24% 62
2024
Q3
$533K Hold
601
0.28% 58
2024
Q2
$544K Buy
601
+57
+10% +$45.6K 0.31% 55
2024
Q1
$423K Buy
544
+41
+8% +$29.2K 0.25% 69
2023
Q4
$293K Sell
503
-87
-15% -$50.8K 0.19% 73
2023
Q3
$317K Sell
590
-3
-0.5% -$1.55K 0.22% 68
2023
Q2
$278K Sell
593
-28
-5% -$11.7K 0.19% 71
2023
Q1
$213K Buy
621
+2
+0.3% +$675 0.16% 77
2022
Q4
$227K Buy
+619
New +$219K 0.15% 69

Other funds holding LLY

Financial Freedom LLC's LLY Position: Q2 2026 in Review

Financial Freedom LLC held its Eli Lilly (LLY) position steady in Q2 2026 at 621 shares worth $745K. The position accounts for 0.34% of the portfolio, ranked #57.

Financial Freedom LLC first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Financial Freedom LLC held 621 shares of Eli Lilly worth $745K as of Q2 2026.
  • Financial Freedom LLC left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.34% of Financial Freedom LLC's portfolio in Q2 2026, its #57 holding.
  • Financial Freedom LLC first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.